StockTalk | Cannabis Report: The Tilray special
Tilray Medical, a global leader in medical cannabis research, cultivation, production, products and distribution and a division of Tilray Brands, Inc. (TSX/NASDAQ: TLRY), announced that ...
Read the full articleYou might also wanna read
Tilray's Stock Is Down Over 50% This Year. Has It Become a Bargain Buy?
The cannabis stock recently hit a new 52-week low.
Canopy Growth: Is Another Reverse Stock Split Inevitable?
Shares of the cannabis company have fallen below the $1 mark again.
Glass House Brands: America's largest cannabis grower aims for NYSE listing and global expansion after ICE raid
A year after a deadly ICE raid on its massive cannabis farms, Glass House is preparing to trade on the New York Stock Exchange, harvest 1 mi
forbes.com·11d ago
Business Watch: Hardware Store Closures and Industry Deals in Chemicals & Pharma
Here’s what we’re watching in the chemical and pharmaceutical industries this week
cen.acs.org·8d agoBusiness Watch: Hardware Store Closures and Industry Deals in Chemicals & Pharma
Here’s what we’re watching in the chemical and pharmaceutical industries this week
cen.acs.org·8d agoBiotech NRx to sell new shares to fund growth and operations
#NRXP NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
Lexicon Pharmaceuticals (NASDAQ:LXRX) Scores Perfect 10 Technical Rating After 119% Rally
Lexicon Pharmaceuticals (LXRX) shows strong momentum, with 119% yearly gains and perfect technical ratings. The stock passes Minervini's Tre
Comments
Sign in to join the conversation.
No comments yet. Be the first.